AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Invex Therapeutics Ltd

AUD 0.12 -$0.01 (-8.00%)
ASX · 09 Sep 2026 03:10 UTC
Previous Close
AUD 0.12
Day Range
AUD 0.12 - AUD 0.12
Year Range
AUD 0.09AUD 0.18
Market Cap
8.64M
AVG Volume
31.78K
Trailing/Forward PE
-6.39/-
PEG ratio
-0.18
Dividend Yield
-
Next Earnings Date
2027-02-18
Primary Exchange
Australian Securities ExchangeAU
Revenue (AUD)
0500K1M1.5M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Revenue (AUD) by quarter
PeriodRevenue (AUD)
26 Q40
26 Q20
25 Q4229.08K
25 Q20
24 Q41.21M
24 Q20
23 Q412.18K
23 Q2446.91K
22 Q4182.25K
22 Q20
Net Income (AUD)
-4M-2M02M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Net Income (AUD) by quarter
PeriodNet Income (AUD)
26 Q4-636.77K
26 Q2-715.58K
25 Q4-120.33K
25 Q2-357K
24 Q4470.89K
24 Q2-2.11M
23 Q4-3.9M
23 Q2-3.85M
22 Q4-2.16M
22 Q2-1.8M
Operating Income (AUD)
-6M-4M-2M02M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Operating Income (AUD) by quarter
PeriodOperating Income (AUD)
26 Q4-701.4K
26 Q2-843.02K
25 Q4-237.12K
25 Q2-472K
24 Q4355.71K
24 Q2-2.49M
23 Q4-4.95M
23 Q2-4.2M
22 Q4-2.2M
22 Q2-2.02M
EBITDA (AUD)
-1M-500K0500K22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX EBITDA (AUD) by quarter
PeriodEBITDA (AUD)
26 Q4-701.4K
26 Q2-843.02K
25 Q40
25 Q2-356.54K
24 Q4-741K
24 Q2376.64K
23 Q40
23 Q20
22 Q4-141K
22 Q20
Cash Flows (AUD)
-4M-3M-2M-1M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
IXC.AX Cash Flows (AUD) by quarter
PeriodCash Flows (AUD)
26 Q2-779.73K
25 Q4-410.96K
25 Q2-241.61K
24 Q4-126.75K
24 Q2-2.32M
23 Q4-2.95M
23 Q2-3.92M
22 Q4-2.03M
22 Q2-1.35M
21 Q4-865.7K
EPS (AUD)
-0.06-0.04-0.0200.0222 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX EPS (AUD) by quarter
PeriodEPS (AUD)
26 Q4-0.01
26 Q2-0.01
25 Q4-0
25 Q2-0
24 Q40.01
24 Q2-0.03
23 Q4-0.05
23 Q2-0.05
22 Q4-0.03
22 Q2-0.02
Expenses (AUD)
02M4M6MR&DSG&A22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Expenses (AUD) by quarter
PeriodExpenses (AUD)
26 Q4701.4K
26 Q2843.02K
25 Q4466.2K
25 Q2472.19K
24 Q4856.54K
24 Q22.49M
23 Q44.66M
23 Q24.34M
22 Q42.2M
22 Q21.88M
Cash & Debt (AUD)
010M20M30M40M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Cash & Debt (AUD) by quarter
PeriodCash & Debt (AUD)
26 Q44.02M
26 Q24.6M
25 Q45.38M
25 Q25.81M
24 Q46.03M
24 Q26.15M
23 Q422.47M
23 Q225.42M
22 Q429.34M
22 Q231.37M
Debt ratios
-1000-500050022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Debt ratios by quarter
PeriodDebt ratios
26 Q42.11
26 Q22.37
25 Q47.46
25 Q28.05
24 Q416.54
24 Q2-26.11
23 Q4159.36
23 Q2262.74
22 Q4303.21
22 Q2-709.06
Margins
-3000%-2000%-1000%0%1000%22 Q423 Q223 Q424 Q425 Q4
IXC.AX Margins by quarter
PeriodMargins
25 Q4100%
24 Q4100%
23 Q4-2365.5%
23 Q232.78%
22 Q422.73%
Return on Capital
-40%-20%0%20%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Return on Capital by quarter
PeriodReturn on Capital
26 Q4-16.29%
26 Q2-15.74%
25 Q4-2.29%
25 Q2-6.63%
24 Q48.28%
24 Q2-39.9%
23 Q4-18.38%
23 Q2-15.56%
22 Q4-7.57%
22 Q2-5.88%
Shares Outstanding
020M40M60M80M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Shares Outstanding by quarter
PeriodShares Outstanding
26 Q475.15M
26 Q275.15M
25 Q475.53M
25 Q275.86M
24 Q475.45M
24 Q275.15M
23 Q475.18M
23 Q275.16M
22 Q475.15M
22 Q275.78M
Dividends (AUD)
00.511.5Dec 23
IXC.AX Dividends (AUD) by quarter
PeriodDividends (AUD)
Dec 230.19
Book Value Per Share (AUD)
00.20.40.622 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Book Value Per Share (AUD) by quarter
PeriodBook Value Per Share (AUD)
26 Q40.05
26 Q20.06
25 Q40.07
25 Q20.07
24 Q40.08
24 Q20.07
23 Q40.28
23 Q20.33
22 Q40.38
22 Q20.4
Total Assets (AUD)
010M20M30M40M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
IXC.AX Total Assets (AUD) by quarter
PeriodTotal Assets (AUD)
26 Q44.06M
26 Q24.72M
25 Q45.47M
25 Q25.86M
24 Q46.12M
24 Q26.28M
23 Q422.8M
23 Q225.9M
22 Q429.49M
22 Q231.51M
Free Cash Flow Yield
-250%-200%-150%-100%-50%0%med -43.73%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IXC.AX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-18.04%
Sep 26-19.76%
Aug 26-15.96%
Aug 26-17.29%
Aug 26-18.04%
Aug 26-18.04%
Jul 26-18.86%
Jul 26-17.29%
Jul 26-20.74%
Jul 26-19.76%
Jul 26-21.84%
Jun 26-20.74%
Jun 26-15.96%
Jun 26-17.29%
Jun 26-18.86%
May 26-18.86%
May 26-17.29%
May 26-16.6%
May 26-15.96%
May 26-15.96%
Apr 26-20.74%
Apr 26-22.31%
Apr 26-23.05%
Apr 26-20.74%
Mar 26-41%
Mar 26-41%
Mar 26-39.05%
Mar 26-34.17%
Feb 26-32.8%
Feb 26-32.8%
Feb 26-37.27%
Feb 26-34.17%
Jan 26-31.54%
Jan 26-35.65%
Jan 26-35.65%
Jan 26-37.27%
Jan 26-32.8%
Dec 25-32.8%
Dec 25-35.65%
Dec 25-34.17%
Dec 25-34.17%
Nov 25-37.27%
Nov 25-34.17%
Nov 25-30.37%
Nov 25-35.65%
Oct 25-35.65%
Oct 25-31.54%
Oct 25-29.29%
Oct 25-28.28%
Oct 25-34.17%
Sep 25-46.46%
Sep 25-70.8%
Sep 25-74.34%
Sep 25-78.25%
Aug 25-74.34%
Aug 25-76.64%
Aug 25-99.12%
Aug 25-82.6%
Aug 25-80.8%
Jul 25-89.57%
Jul 25-82.6%
Jul 25-82.6%
Jul 25-81.69%
Jun 25-83.53%
Jun 25-85.45%
Jun 25-81.69%
Jun 25-79.94%
May 25-79.94%
May 25-79.94%
May 25-79.94%
May 25-75.09%
May 25-92.92%
Apr 25-106.2%
Apr 25-106.2%
Apr 25-106.2%
Apr 25-109.32%
Mar 25-181.52%
Mar 25-173.85%
Mar 25-187.02%
Mar 25-205.72%
Feb 25-187.02%
Feb 25-189.9%
Feb 25-164.58%
Feb 25-169.09%
Jan 25-176.33%
Jan 25-166.8%
Jan 25-171.43%
Jan 25-176.33%
Jan 25-176.33%
Dec 24-187.02%
Dec 24-184.23%
Dec 24-166.8%
Dec 24-171.43%
Nov 24-184.23%
Nov 24-162.41%
Nov 24-154.29%
Nov 24-137.15%
Nov 24-137.15%
Oct 24-160.3%
Oct 24-143.53%
Price to Sales
246810med 5.67Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IXC.AX Price to Sales by quarter
PeriodPrice to Sales
Sep 266
Sep 265.48
Aug 266.78
Aug 266.26
Aug 266
Aug 266
Jul 265.74
Jul 266.26
Jul 265.22
Jul 265.48
Jul 264.95
Jun 265.22
Jun 266.78
Jun 266.26
Jun 265.74
May 265.74
May 266.26
May 266.52
May 266.78
May 266.78
Apr 265.22
Apr 264.85
Apr 264.69
Apr 265.22
Mar 265.24
Mar 265.24
Mar 265.5
Mar 266.29
Feb 266.55
Feb 266.55
Feb 265.77
Feb 266.29
Jan 266.81
Jan 266.03
Jan 266.03
Jan 265.77
Jan 266.55
Dec 256.55
Dec 256.03
Dec 256.29
Dec 256.29
Nov 255.77
Nov 256.29
Nov 257.08
Nov 256.03
Oct 256.03
Oct 256.81
Oct 257.34
Oct 257.6
Oct 256.29
Sep 259.91
Sep 256.51
Sep 256.2
Sep 255.89
Aug 256.2
Aug 256.01
Aug 254.65
Aug 255.58
Aug 255.7
Jul 255.14
Jul 255.58
Jul 255.58
Jul 255.64
Jun 255.52
Jun 255.39
Jun 255.64
Jun 255.76
May 255.76
May 255.76
May 255.76
May 256.13
May 254.96
Apr 254.34
Apr 254.34
Apr 254.34
Apr 254.21
Mar 253.07
Mar 253.21
Mar 252.98
Mar 252.71
Feb 252.98
Feb 252.93
Feb 253.39
Feb 253.3
Jan 253.16
Jan 253.34
Jan 253.25
Jan 253.16
Jan 253.16
Dec 242.98
Dec 243.03
Dec 243.34
Dec 243.25
Nov 243.03
Nov 243.43
Nov 243.61
Nov 244.06
Nov 244.06
Oct 243.48
Oct 243.88
EV/EBITDA
-2000200400600med 222.41Nov 21Jan 22Apr 22Jul 22Apr 24Jul 24Sep 24
IXC.AX EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 24-2.19
Sep 24-2.19
Sep 24-3.14
Sep 24-3.46
Aug 24-3.78
Aug 24-3.14
Aug 24-3.78
Aug 24-3.46
Aug 24-3.46
Jul 24-3.14
Jul 24-1.87
Jul 24-5.06
Jul 24-5.06
Jun 24-6.97
Jun 24-2.51
Jun 24-3.78
Jun 24-1.23
May 24-0.59
May 240.68
May 24-1.87
May 24-1.23
May 24-0.59
Apr 24-0.59
Apr 240.36
Apr 242.6
Apr 242.28
Sep 22318.72
Sep 22395.81
Sep 22284.46
Sep 22301.59
Aug 22387.24
Aug 22404.37
Aug 22241.64
Aug 22164.55
Jul 22224.51
Jul 22164.55
Jul 22181.68
Jul 22147.42
Jul 22121.73
Jun 2236.08
Jun 22121.73
Jun 22173.12
Jun 22164.55
May 22190.25
May 22233.07
May 22327.29
May 22395.81
Apr 22464.32
Apr 22541.41
Apr 22575.67
Apr 22438.63
Apr 22352.98
Mar 22322.25
Mar 22220.32
Mar 22203.33
Mar 22262.79
Feb 22194.83
Feb 22274.68
Feb 22279.78
Feb 22262.79
Jan 22296.77
Jan 22441.18
Jan 22483.65
Jan 22492.15
Dec 21458.17
Dec 21398.7
Dec 21390.21
Dec 21449.67
Dec 21364.73
Nov 21415.69
Nov 21313.76
Nov 21398.7
Nov 21432.68
Oct 21373.22
Oct 21509.14
Oct 21449.67
Oct 21432.68
Oct 21449.67
Price to Book
0.511.522.5med 1.46Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IXC.AX Price to Book by quarter
PeriodPrice to Book
Sep 261.9
Sep 261.74
Aug 262.15
Aug 261.98
Aug 261.9
Aug 261.9
Jul 261.82
Jul 261.98
Jul 261.65
Jul 261.74
Jul 261.57
Jun 261.65
Jun 262.15
Jun 261.98
Jun 261.82
May 261.82
May 261.98
May 262.07
May 262.15
May 262.15
Apr 261.65
Apr 261.54
Apr 261.49
Apr 261.65
Mar 261.44
Mar 261.44
Mar 261.51
Mar 261.73
Feb 261.8
Feb 261.8
Feb 261.58
Feb 261.73
Jan 261.87
Jan 261.66
Jan 261.66
Jan 261.58
Jan 261.8
Dec 251.8
Dec 251.66
Dec 251.73
Dec 251.73
Nov 251.58
Nov 251.73
Nov 251.94
Nov 251.66
Oct 251.66
Oct 251.87
Oct 252.02
Oct 252.09
Oct 251.73
Sep 252.25
Sep 251.48
Sep 251.41
Sep 251.34
Aug 251.41
Aug 251.37
Aug 251.06
Aug 251.27
Aug 251.3
Jul 251.17
Jul 251.27
Jul 251.27
Jul 251.28
Jun 251.25
Jun 251.23
Jun 251.28
Jun 251.31
May 251.31
May 251.31
May 251.31
May 251.39
May 251.13
Apr 250.99
Apr 250.99
Apr 250.99
Apr 250.96
Mar 250.9
Mar 250.94
Mar 250.88
Mar 250.8
Feb 250.88
Feb 250.86
Feb 250.99
Feb 250.97
Jan 250.93
Jan 250.98
Jan 250.96
Jan 250.93
Jan 250.93
Dec 240.88
Dec 240.89
Dec 240.98
Dec 240.96
Nov 240.89
Nov 241.01
Nov 241.06
Nov 241.19
Nov 241.19
Oct 241.02
Oct 241.14
Invex Therapeutics Ltd
IXC.AX
Stockpicker

Video analysis: IXC.AX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.